| Grb2 signaling in cell motility and cancer A Giubellino, TR Burke, DP Bottaro Expert opinion on therapeutic targets 12 (8), 1021-1033, 2008 | 267 | 2008 |
| Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice P Xekouki, E Szarek, P Bullova, A Giubellino, M Quezado, ... The Journal of Clinical Endocrinology & Metabolism 100 (5), E710-E719, 2015 | 155 | 2015 |
| Hereditary papillary renal carcinoma type I PG Dharmawardana, A Giubellino, DP Bottaro Current Molecular Medicine 4 (8), 855-868, 2004 | 112 | 2004 |
| Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy PG Dharmawardana, B Peruzzi, A Giubellino, TR Burke Jr, DP Bottaro Anti-cancer drugs 17 (1), 13-20, 2006 | 104 | 2006 |
| c-Met ectodomain shedding rate correlates with malignant potential G Athauda, A Giubellino, JA Coleman, C Horak, PS Steeg, MJ Lee, ... Clinical cancer research 12 (14), 4154-4162, 2006 | 98 | 2006 |
| Targeting the Met signaling pathway in renal cancer A Giubellino, WM Linehan, DP Bottaro Expert review of anticancer therapy 9 (6), 785-793, 2009 | 94 | 2009 |
| Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r E Le Pape, T Passeron, A Giubellino, JC Valencia, R Wolber, VJ Hearing Proceedings of the National Academy of Sciences 106 (6), 1802-1807, 2009 | 87 | 2009 |
| Directed discovery of agents targeting the Met tyrosine kinase domain by virtual screening ML Peach, N Tan, SJ Choyke, A Giubellino, G Athauda, TR Burke Jr, ... Journal of medicinal chemistry 52 (4), 943-951, 2009 | 78 | 2009 |
| Inhibition of tumor metastasis by a growth factor receptor bound protein 2 src homology 2 domain–binding antagonist A Giubellino, Y Gao, S Lee, MJ Lee, JR Vasselli, S Medepalli, JB Trepel, ... Cancer research 67 (13), 6012-6016, 2007 | 56 | 2007 |
| Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma E Domingo-Musibay, P Murugan, A Giubellino, S Sharma, D Steinberger, ... Journal for Immunotherapy of Cancer 6, 1-7, 2018 | 55 | 2018 |
| Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in … A Giubellino, P Bullova, S Nölting, H Turkova, JF Powers, Q Liu, ... Endocrinology 154 (2), 646-655, 2013 | 55 | 2013 |
| Pheochromocytoma: implications in tumorigenesis and the actual management U Shah, A Giubellino, K Pacak Minerva endocrinologica 37 (2), 141, 2012 | 52 | 2012 |
| Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines S Nölting, E Garcia, G Alusi, A Giubellino, K Pacak, M Korbonits, ... Journal of molecular endocrinology 49 (2), 79, 2012 | 49 | 2012 |
| Analyses of molecular and histopathologic features and expression of PRAME by immunohistochemistry in mucosal melanomas A Toyama, L Siegel, AC Nelson, M Najmuddin, L Bu, R LaRue, C Henzler, ... Modern Pathology 32 (12), 1727-1733, 2019 | 44 | 2019 |
| Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma A Giubellino, C Sourbier, MJ Lee, B Scroggins, P Bullova, M Landau, ... PLoS One 8 (2), e56083, 2013 | 42 | 2013 |
| Current and future therapeutic approaches for metastatic pheochromocytoma and paraganglioma: focus on SDHB tumors J Matro, A Giubellino, K Pacak Hormone and Metabolic Research 45 (02), 147-153, 2013 | 40 | 2013 |
| NF‐κB inhibition significantly upregulates the norepinephrine transporter system, causes apoptosis in pheochromocytoma cell lines and prevents metastasis in an animal model K Pacak, M Sirova, A Giubellino, L Lencesova, L Csaderova, M Laukova, ... International journal of cancer 131 (10), 2445-2455, 2012 | 39 | 2012 |
| Improved wound remodeling correlates with modulated TGF‐beta expression in skin diabetic wounds following combined red and infrared photobiomodulation treatments R Fekrazad, A Sarrafzadeh, KAM Kalhori, I Khan, PR Arany, A Giubellino Photochemistry and photobiology 94 (4), 775-779, 2018 | 34 | 2018 |
| The current state of treatment and future directions in cutaneous malignant melanoma M Ernst, A Giubellino Biomedicines 10 (4), 822, 2022 | 33 | 2022 |
| Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging A Giubellino, GM Woldemichael, C Sourbier, MJ Lizak, JF Powers, ... Cancer letters 316 (1), 46-52, 2012 | 33 | 2012 |
